Intrinsic value of Xeris Biopharma Holdings, Inc. (XERS)
Live fair value data for Xeris Biopharma Holdings, Inc. (XERS) is currently unavailable. Please check again shortly.
Current Price: $62.00
Valuation: Undervalued
Confidence: 6.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Xeris Biopharma Holdings, Inc. (XERS) undervalued or overvalued?
Based on the current model output, Xeris Biopharma Holdings, Inc. appears to be undervalued with a upside of 25.00%.
Fair value vs market price — Xeris Biopharma Holdings, Inc. (XERS)
Unlock premium access to view the live fair value comparison against current market price for XERS.
Frequently Asked Questions - XERS
How is XERS intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for XERS.
Is XERS undervalued or overvalued right now?
XERS is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for XERS: open their intrinsic value pages.